These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Retard implantation tablets on a matrix base with Eudragit as a structural substance.
    Author: Korsatko W.
    Journal: Pharmazie; 1982 Apr; 37(4):272-3. PubMed ID: 7100251.
    Abstract:
    A model for prolonged availability of low concentrated drugs was successfully tested by using 7-hydroxyethyltheophylline and Eudragit RS 100 as matrix to form implant-tablets. Those tablets have the same size, same weight, same hardness, but a different concentration of the model substance and are coated with liquid Eudragit RS 100. Statistical evaluation of the different liberation rates led to a drawing of a diagram whereby a desired drug liberation up to 6 d can easily be obtained by choosing a certain drug concentration of the tablet.
    [Abstract] [Full Text] [Related] [New Search]